Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma – case series and literature review

Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma – case series and literature review

Introduction and objective Multiple myeloma (MM) is an incurable condition with variable clinical course. The study included a group of patients with especially poor-prognosis, individuals with relapsed/refractory multiple myeloma (RRMM) and specific cytogenetic disorders. Among the currently used t...

Full description

Bibliographic Details
Main Authors: Aneta Szudy-Szczyrek, Sylwia Chocholska, Oliwia Bachanek-Mitura, Olga Czabak, Radosław Mlak, Michał Szczyrek, Justyna Muzyka-Kasietczuk, Marek Hus
Format: Article
Language:English
Published: Institute of Rural Health 2021-06-01
Series:Annals of Agricultural and Environmental Medicine
Subjects:
lenalidomide
high risk
ixazomib
cytogenetic
relapsed/refractory multiple myeloma
Online Access:http://www.aaem.pl/Efficacy-of-ixazomib-lenalidomide-dexamethasone-in-high-molecular-risk-relapsed-refractory,137788,0,2.html

Internet

http://www.aaem.pl/Efficacy-of-ixazomib-lenalidomide-dexamethasone-in-high-molecular-risk-relapsed-refractory,137788,0,2.html

Similar Items